InvestorsHub Logo
Followers 2
Posts 319
Boards Moderated 0
Alias Born 08/29/2018

Re: None

Sunday, 10/31/2021 11:31:36 AM

Sunday, October 31, 2021 11:31:36 AM

Post# of 27424
Anyone talk to Cesare lately? Are we still or have we ever done business with Baxter? I know the Canadian filter company does business with them now. Baxter gave them 5 million for rights to sell the product as an upfront. The Canadian filter company is well into their phase 4 confirmatory trial with the FDA and are actually seeing their filter used on 2 of every 3 critically ill patients. Perhaps the mosting exciting part of this is the fact the primary endpoint for the trial is 28 day mortality. People have been saying that 28 day mortality is the holy grail for sepsis and could likely never get done in a RCT. Perhaps the use of a companion diagnostic is the solution and perhaps this is why Dr.J Kellum of Pittsburgh moved to a full time role with the Canadian company. Dr. Kellum used to advise for CTSO however I don't see him listed anymore. Just curious on everyone's thoughts here, is the Canadian company making covert advances that seem to elude even the smartest investors with CTSO? Anyway, here is Cesare's words from a few years back, I had saved it in my CTSO folder..


caesare74 Wednesday, 11/01/17 06:06:00 PM
Re: mikesmith999945 post# 10145 0
Post #
10148
of 26835
correcet Mike. I forgot to mention Baxter. As you say, something very positiv is definitely on the radar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News